These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11997082)

  • 21. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
    Stier S; Neuhaus T; Albers P; Wernert N; Grünewald E; Forkert R; Vetter H; Ko Y
    Arch Toxicol; 2006 Oct; 80(10):713-8. PubMed ID: 16721595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma.
    Wu MS; Wang HP; Lin CC; Sheu JC; Shun CT; Lee WJ; Lin JT
    Cancer Lett; 1997 Nov; 120(1):9-14. PubMed ID: 9570380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction.
    Tabano S; Colapietro P; Cetin I; Grati FR; Zanutto S; Mandò C; Antonazzo P; Pileri P; Rossella F; Larizza L; Sirchia SM; Miozzo M
    Epigenetics; 2010 May; 5(4):313-24. PubMed ID: 20418667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
    Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
    Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
    Kim HT; Choi BH; Niikawa N; Lee TS; Chang SI
    Am J Med Genet; 1998 Dec; 80(4):391-5. PubMed ID: 9856569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma.
    Albrecht S; Waha A; Koch A; Kraus JA; Goodyer CG; Pietsch T
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1270-6. PubMed ID: 8957451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.
    Vu TH; Nguyen AH; Hoffman AR
    Hum Mol Genet; 2010 Mar; 19(5):901-19. PubMed ID: 20015958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
    Rainho CA; Kowalski LP; Rogatto SR
    Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
    Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of imprinting in hepatoblastoma.
    Rainier S; Dobry CJ; Feinberg AP
    Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients.
    Tian F; Tang Z; Song G; Pan Y; He B; Bao Q; Wang S
    Mol Med Rep; 2012 Jun; 5(6):1536-40. PubMed ID: 22427002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic imprinting of IGF2 and H19 in human meningiomas.
    Müller S; Zirkel D; Westphal M; Zumkeller W
    Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
    Gao T; He B; Pan Y; Gu L; Chen L; Nie Z; Xu Y; Li R; Wang S
    Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.
    Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K
    Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF2 but not H19 shows loss of imprinting in human glioma.
    Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
    Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma.
    Grbesa I; Ivkic M; Pegan B; Gall-Troselj K
    Cancer Lett; 2006 Jul; 238(2):224-9. PubMed ID: 16111804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors.
    Ross JA; Schmidt PT; Perentesis JP; Davies SM
    Cancer; 1999 Mar; 85(6):1389-94. PubMed ID: 10189147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.
    Nakagawa H; Chadwick RB; Peltomaki P; Plass C; Nakamura Y; de La Chapelle A
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):591-6. PubMed ID: 11120891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
    Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
    Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma.
    Casola S; Pedone PV; Cavazzana AO; Basso G; Luksch R; d'Amore ES; Carli M; Bruni CB; Riccio A
    Oncogene; 1997 Mar; 14(12):1503-10. PubMed ID: 9136994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.